Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mitsuhiro Itagaki
Observed names:
Itagaki Mitsuhiro,
M Itagaki,
M. Itagaki
Institution:
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
Observed institution:
Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
ORCID:
0009-0004-7549-4911
Observed ORCID:
0009-0004-7549-4911
OpenAlex ID:
A5089172159
Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese Society of Myeloma
2015
·
S Ozaki
, H Handa
, et al.
·
Blood Cancer Journal
·
72
PDF
Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation
2014
·
Shuji Ozaki
, Takeshi Harada
, et al.
·
Acta Haematologica
·
54
PDF
Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
2012
·
Yuka Aoki
, Masanori Nojima
, et al.
·
Genome Medicine
·
46
PDF
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine
2021
·
Yutaka Shimazu
, Shohei Mizuno
, et al.
·
Cancer Science
·
22
PDF
Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma
2019
·
Shuji Ozaki
, Hiroshi Handa
, et al.
·
Annals of Hematology
·
17
A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival
2021
·
Takeshi Yamashita
, Hiroyuki Takamatsu
, et al.
·
British Journal of Haematology
·
16
PDF
Prognostic value of minimal residual disease detected by EuroFlow next-generation flow cytometry and next-generation sequencing in patients with multiple myeloma achieving complete response and receiving lenalidomide maintenance after autotransplant: a prospective comparison study
2025
·
Takeshi Yoroidaka
, Hiroyuki Takamatsu
, et al.
·
Haematologica
·
12
PDF
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)
2024
·
Hirohiko Shibayama
, Mitsuhiro Itagaki
, et al.
·
International Journal of Hematology
·
12
PDF
Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective Analysis
2023
·
Kazuhito Suzuki
, Yutaka Shimazu
, et al.
·
Transplantation and Cellular Therapy
·
10
Establishment of an HS23 stromal cell-dependent myeloma cell line: fibronectin and IL-6 are critical
2010
·
Akira Sakai
, Miyo Oda
, et al.
·
International Journal of Hematology
·
7
Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis
2023
·
Kazuhito Suzuki
, Shohei Mizuno
, et al.
·
European Journal Of Haematology
·
6
PDF
Post-allogeneic stem cell transplant extramedullary relapse of acute megakaryoblastic leukemia initially detected by elevated WT1 mRNA levels in peripheral blood.
2016
·
Tetsuro Ochi
, Koji Iwato
, et al.
·
PubMed
·
5
[Acute leukemia recurring as extramedullary tumors of the ovary following allogeneic hematopoietic stem cell transplantation].
2018
·
Ryouta Imanaka
, Yuta Katayama
, et al.
·
PubMed
·
4
The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation
2024
·
Yutaka Shimazu
, Junya Kanda
, et al.
·
Cancer Science
·
3
Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis
2017
·
Testuro Ochi
, Yuta Katayama
, et al.
·
Medical Mycology Case Reports
·
3
PDF
[Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by concomitant Achromobacter xylosoxidans and Corynebacterium striatum bacteremia following allogeneic hematopoietic stem cell transplantation].
2017
·
Yuta Katayama
, Kouhei Kyo
, et al.
·
PubMed
·
3
Comparison of stem cell mobilization methods in multiple myeloma
2025
·
Yutaka Shimazu
, Nobuhiro Tsukada
, et al.
·
Cytotherapy
·
2
Loss‐Prone HLA Class I Alleles Inform Outcomes of Early Hematopoietic Cell Transplantation in Acquired Aplastic Anemia
2025
·
Yoshitaka Zaimoku
, Hirohito Yamazaki
, et al.
·
American Journal of Hematology
·
2
Frequent loss of HLA‐B*40:02 from leucocytes in male patients with hepatitis‐associated aplastic anaemia
2024
·
Takamasa Katagiri
, Rio Takahashi
, et al.
·
British Journal of Haematology
·
2
PDF
Prospective Comparison Study of Prognostic Value of MRD Detected By 8-Color MFC (EuroFlow-NGF) and NGS in Patients with Multiple Myeloma in ASCT Setting
2021
·
Takeshi Yoroidaka
, Hiroyuki Takamatsu
, et al.
·
Blood
·
2
Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma
2018
·
Tetsuhiro Kasamatsu
, Shuji Ozaki
, et al.
·
Hematological Oncology
·
2
Correction: Genomic vulnerability to LINE-1 hypomethylation is a potential determinant of the clinicogenetic features of multiple myeloma
2013
·
Yuka Aoki
, Masanori Nojima
, et al.
·
Genome Medicine
·
2
PDF
Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis
2018
·
Tatsuji Mino
, Yuta Katayama
, et al.
·
Blood
·
1
Intravascular Large B-cell Lymphoma with a Pulmonary [18F]-Fluorodeoxyglucose Uptake
2018
·
Masahiro Yamasaki
, Mitsuhiro Itagaki
, et al.
·
Internal Medicine
·
1
Central Nervous System Invasion in Multiple Myeloma: A Nationwide Survey of 75 Patients in Japan
2016
·
Takeshi Yamashita
, Hiroyuki Takamatsu
, et al.
·
Blood
·
1
Show more works
View as search
Works count:
53
Citation count:
309
H-index:
9
I10-index:
9
Year
Topic
Type